Dihydrofolate reductase and its use

The method of biosynthesizing 6-S-tetrahydrofolate in vitro using dihydrofolate reductase solves the problems of difficult resolution, low yield, and high pollution associated with the existing chemical synthesis of L-5-methyltetrahydrofolate, achieving a highly efficient and environmentally friendly production process.

CN116376859BActive Publication Date: 2026-11-10JIANGSU OCEAN UNIV +1
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202310142831.1
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-02-21
Publication Date
2026-11-10
Estimated Expiration
2043-02-21

AI Technical Summary

Technical Problem

Existing methods for the chemical synthesis of L-5-methyltetrahydrofolate suffer from difficulties in resolution, low yield, and high pollution, making industrialization challenging.

Method used

The method of in vitro biosynthesis of 6-S-tetrahydrofolate using dihydrofolate reductase involves constructing a recombinant vector containing dihydrofolate reductase, transferring it into Escherichia coli, and conducting an enzymatic reaction to generate 6-S-tetrahydrofolate.

Benefits of technology

It greatly reduces production costs, eliminates environmental impact, is easy to operate, and has high conversion rate and product purity, making it suitable for industrial applications.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN116376859B_ABST
    Figure CN116376859B_ABST
Patent Text Reader

Abstract

This invention discloses a dihydrofolate reductase and its applications. The amino acid sequence of the dihydrofolate reductase is selected from SEQ ID NO.1, SEQ ID NO.2, SEQ ID NO.3, or SEQ ID NO.4. The dihydrofolate reductase used for the in vitro biosynthesis of 6-S-tetrahydrofolate significantly reduces production costs and eliminates the environmental impact of byproduct processing. Furthermore, the operation is simple, the conditions are mild, the time is short, and the conversion rate and product purity are both above 86%, making it suitable for industrial application.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of fine chemical technology, and in particular to a dihydrofolate reductase and its application in the in vitro biosynthesis of 6-S-tetrahydrofolate. Background Technology

[0002] L-5-methyltetrahydrofolate (L-5-MTHF) is a novel folic acid drug that is increasingly being used in pharmaceuticals and food. L-5-MTHF has become a new type of vitamin supplement on the international market. It can be used as a food additive and a key ingredient in some nutritional supplements without producing any side effects, while also possessing good therapeutic effects and functions.

[0003] Folic acid exists primarily in the blood and tissues of the human body in the form of L-5-MTHF, participating in many biochemical reactions. L-5-MTHF is the main form in which folic acid functions in the body; it can be directly absorbed and utilized by the body without undergoing complex enzymatic reactions. Folic acid is mainly absorbed in the upper small intestine, where it is metabolized to produce L-5-MTHF. Folic acid is further divided into monoglutamate folic acid and polyglutamate folic acid. The former can be directly absorbed and utilized by the small intestine without metabolism, while the latter requires breakdown by carboxypeptidase secreted by the intestinal epithelial cells before it can be absorbed and utilized by the small intestine. After being absorbed by the small intestine, folic acid is reduced to dihydrofolate under the combined action of coenzyme-reduced nicotinamide adenine dinucleotide (NADPH) and dihydrofolate reductase. Dihydrofolate is then reduced by reduced coenzyme II and ascorbic acid, metabolizing to produce biologically active THF. Finally, THF is methylated in the liver to produce methyltetrahydrofolate, which is ultimately utilized by the body. Biochemically active folic acid involves a series of enzymatic reactions and cofactors. Absorbed folic acid is reduced and methylated to 5-MTHF during metabolism in intestinal mucosal cells. The methyl donor participates in multiple biochemical processes. It can also act as a donor in nucleotide synthesis, supporting DNA biosynthesis.

[0004] There are many reports on L-5-MTHF, but due to its poor stability and sensitivity to oxygen, its production has not been widely industrialized. Folic acid is relatively inexpensive, making it a promising raw material for the production of L-5-MTHF. Therefore, the synthesis method of 6-S-tetrahydrofolate, as the most important intermediate in the production process, is of paramount importance.

[0005] The existing process for synthesizing 6-S-methyltetrahydrofolate involves folic acid as a raw material, through reduction and resolution steps. However, methods for the chemical synthesis of L-5-methyltetrahydrofolate calcium suffer from numerous problems, including difficulty in resolution, low yield, significant pollution, and challenges in industrialization. Therefore, finding a method alternative to chemical synthesis has become a very practically significant endeavor. Summary of the Invention

[0006] Objectives of the Invention: The first objective of this invention is to provide a dihydrofolate reductase for the in vitro synthesis of 6-S-tetrahydrofolate; the second objective of this invention is to provide the gene or nucleic acid encoding the above-mentioned dihydrofolate reductase; the third objective of this invention is to provide the application of the above-mentioned dihydrofolate reductase in the in vitro biosynthesis of 6-S-tetrahydrofolate; and the fourth objective of this invention is to provide a method for the in vitro biosynthesis of 6-S-tetrahydrofolate using the above-mentioned dihydrofolate reductase.

[0007] Technical solution: The amino acid sequence of the dihydrofolate reductase described in this invention is selected from SEQ ID NO.1, SEQ ID NO.2, SEQ ID NO.3 or SEQ ID NO.4.

[0008] The dihydrofolate reductase with the amino acid sequence SEQ ID NO.1 is named DHFR-1, the dihydrofolate reductase with the amino acid sequence SEQ ID NO.2 is named DHFR-2, the dihydrofolate reductase with the amino acid sequence SEQ ID NO.3 is named DHFR-3, and the dihydrofolate reductase with the amino acid sequence SEQ ID NO.4 is named DHFR-4.

[0009] The gene or nucleic acid encoding the above-mentioned dihydrofolate reductase described in this invention.

[0010] Furthermore, the nucleotide sequence of the gene or nucleic acid of the dihydrofolate reductase is selected from SEQ ID NO.5, SEQ ID NO.6, SEQ ID NO.7 or SEQ ID NO.8.

[0011] The application of the dihydrofolate reductase, the gene or nucleic acid encoding it described in this invention in the in vitro biosynthesis of 6-S-tetrahydrofolate.

[0012] The present invention discloses an in vitro biosynthesis method for 6-S-tetrahydrofolate, comprising the following steps:

[0013] A recombinant vector containing the above-mentioned dihydrofolate reductase gene was constructed, and the recombinant vector was transferred into Escherichia coli to obtain a recombinant Escherichia coli culture. The recombinant Escherichia coli culture was lysed to obtain a dihydrofolate reductase solution. Folic acid, sodium hydroxide aqueous solution and reducing agent were mixed to obtain dihydrofolate. Dihydrofolate, dihydrofolate reductase solution and coenzyme factor were mixed and subjected to an enzymatic reaction. After the reaction was completed, 6-S-tetrahydrofolate was obtained.

[0014] Furthermore, the lysis conditions of the Escherichia coli culture in step (2) are 20,000-35,000 g / min and centrifugation time is 30-60 min.

[0015] Furthermore, it also includes purification treatment of dihydrofolate reductase solution and / or immobilized enzyme treatment.

[0016] Further, the purification process includes: passing the crude enzyme solution obtained by lysing the recombinant Escherichia coli bacterial culture through a Ni column and eluting it with imidazole solutions of different gradients; then passing the Ni column eluent with the highest enzyme content through a Q column and eluting it with salt solutions of different gradients (mainly KCl) to obtain a preliminarily purified enzyme solution; and then dialyzing the preliminarily purified enzyme solution to obtain a purified enzyme solution.

[0017] Furthermore, during the fabrication of the immobilized enzyme, the immobilization carrier can be selected from, but is not limited to, amino resin and epoxy resin; the pH value of the reaction system is 4-9 and the reaction time is 1-6 hours.

[0018] Furthermore, the reducing agent is zinc powder or sodium dithionite.

[0019] Furthermore, the coenzyme factor is NADH or NADPH, the temperature of the enzymatic reaction is 20-45℃, the pH value of the enzymatic reaction is 5-9, and the reaction time is 1-24h.

[0020] Furthermore, the mass ratio of the coenzyme factor to dihydrofolate is 0.1-3:1, and the mass ratio of the dihydrofolate reductase solution to dihydrofolate is 0.002-0.01:1.

[0021] Furthermore, the enzymatic reaction also includes glucose and glucose dehydrogenase, with the mass ratio of glucose, dihydrofolate, and coenzyme factor being 0.4-1:1:0.01-1, and the mass ratio of glucose to glucose dehydrogenase being 0.001-0.01:1.

[0022] Beneficial Effects: Compared with existing technologies, this invention has the following significant advantages: This invention discloses a dihydrofolate reductase, which greatly reduces production costs and eliminates the environmental impact of byproduct processing when used for the in vitro biosynthesis of 6-S-tetrahydrofolate. Furthermore, it is simple to operate, operates under mild conditions, and is quick to use, with conversion rates and product purity both exceeding 86%, making it suitable for industrial applications. Attached Figure Description

[0023] Figure 1 This is a high-performance liquid chromatogram of dihydrofolic acid.

[0024] Figure 2 The high-performance liquid chromatogram of 6-S-tetrahydrofolate.

[0025] Figure 3 The high-performance liquid chromatogram is shown in the biocatalytic synthesis method of the present invention for preparing 6-S-tetrahydrofolate. Detailed Implementation

[0026] The technical solution of the present invention will be further described below with reference to the accompanying drawings.

[0027] The pET28a vector used in the following examples was preserved in the laboratory of Jiangsu Ocean University, and the E. coli DE3 competent cells (CB105) were obtained from Tiangen Biotech Co., Ltd. The amino acid sequence of glucose dehydrogenase is GenBank: KAF2407874.1. PBS buffer preparation method: Weigh 40g NaCl, 1g KCl, 7.2g Na2HPO4, and 1.2g KH2PO4 and dissolve them in 800mL distilled water. Adjust the solution to 7.0 with HCl, and finally add distilled water to a final volume of 1L to obtain 50mM PBS buffer.

[0028] Example 1. Reduction of folic acid to dihydrofolic acid

[0029] Dissolve 9g of folic acid in 50ml of 15% sodium hydroxide aqueous solution, then add 2g of zinc powder and control the reaction until the raw folic acid reacts completely. Then neutralize the pH to 7.5, filter to remove the precipitate, and obtain dihydrofolic acid solution. HPLC analysis showed that the purity of the crude product dihydrofolic acid was 95.2%. After recrystallization, 7.31g of purified dihydrofolic acid was obtained with a purity of 99.2%.

[0030] Example 2. Reduction of dihydrofolate to 6-S-tetrahydrofolate

[0031] 2.1 Construction of dihydrofolate reductase

[0032] The selected dihydrofolate reductase nucleotide sequence (SEQ ID NO. 5) was ligated to the vector pET28a using a seamless cloning method to obtain the recombinant vector pET28a-DHFR-1. The ligation vector was then subjected to the following procedures: 10 μl of the ligation product was added to 100 μl of *E. coli* BL21(DE3) competent cells in an ice bath, followed by an ice bath for 30 min, a heat shock at 42°C for 60 s, and another ice bath for 5 min. 300 μl of antibiotic-free LB medium at 37°C was added to the tube, and the mixture was incubated at 37°C and 200 rpm for 1 h. The culture was then plated onto a kanamycin-resistant solid LB agar plate and incubated at 37°C. After colonies grew, single colonies were picked using an autoclaved toothpick. These colonies were then streaked on a kanamycin-resistant LB agar plate for preservation, with the corresponding bacteria and streaked areas marked. Finally, the toothpick was placed in 20 μl of PCR medium containing T7 universal primers. The mixture was stirred thoroughly and PCR amplification was performed. The PCR reaction conditions were: 95℃ for 15 min, 94℃ for 15 s for denaturation, 55℃ for 15 s for annealing, 72℃ for 1 min for extension, for 30 cycles, and finally 72℃ for 5 min. After PCR amplification, the results were observed by electrophoresis. A positive clone was obtained, which is the recombinant Escherichia coli strain containing the target enzyme gene: pET28a-DHFR-1 recombinant Escherichia coli.

[0033] 2.2 Expression of dihydrofolate reductase

[0034] Recombinant pET28a-DHFR-1 Escherichia coli was picked and cultured in LB medium containing kanamycin at 37°C until the OD reached approximately 0.8. IPTG was then added to a final concentration of 0.1 mM, and the culture was induced at 28°C for 16 h. The bacterial cells were then collected by centrifugation at 7000 g / min for 6 min. After discarding the supernatant, the bacterial cells were resuspended in 20 mM PBS solution at a ratio of 1 g:5 ml (bacterial weight:PBS solution). The resuspended cells were then disrupted using a high-pressure cell disruptor to obtain an enzyme-containing lysate. After centrifugation at 35000 g / min for 30 min, the supernatant was extracted to obtain a crude enzyme solution of dihydrofolate reductase DHFR-1.

[0035] 2.3 Purification of dihydrofolate reductase

[0036] The crude dihydrofolate reductase (DHFR-1) enzyme solution was then passed through a Ni column, followed by washing with 150 mM imidazole solution, and then eluting with 500 mM imidazole solution. All Ni column eluent containing the target enzyme was then passed through a Q column, followed by washing with 200 mM salt solution, and then eluting with 1 M salt solution (mainly KCl) to obtain a preliminarily purified enzyme solution. The preliminarily purified enzyme solution was dialyzed for 12 hours to finally obtain the purified dihydrofolate reductase (DHFR-1) enzyme solution.

[0037] Example 3: Enzymatic reaction to produce 6-S-tetrahydrofolate

[0038] Using the dihydrofolate obtained in Example 1 as a substrate, 1g of substrate, 1.8g of NADPH, and 7ml of 20mM PBS solution were added to a 50mL glass reaction flask. Then, 3ml (16.7mg) of the purified dihydrofolate reductase DHFR-1 enzyme solution obtained in step 2.3 was added to the reaction flask to start the reaction. The reaction temperature was 37℃, the pH of the reaction solution was controlled at 7.5, and the reaction was carried out for 8 hours after stirring.

[0039] After the above reaction is completed, the solution is thermally deactivated. After passing through a 0.22 μm filter membrane, 5 μl of the solution is taken for detection by high performance liquid chromatography. The conversion rate is calculated to be >98.9%, the yield to be >93.9%, and the ee value to be >99%.

[0040] Example 4. Enzymatic reaction to produce 6-S-tetrahydrofolate

[0041] Replace 1.8g NADPH with 1.8g NADH, and follow the same steps and conditions as in Example 3.

[0042] The calculated product conversion rate is >86.4%, yield is >80.2%, and ee value is >99%.

[0043] Example 5. Enzymatic reaction to produce 6-S-tetrahydrofolate

[0044] Replace the purified dihydrofolate reductase DHFR-1 enzyme solution with the crude dihydrofolate reductase DHFR-1 enzyme solution obtained in step 2.2. The remaining steps and conditions are the same as in Example 3.

[0045] The calculated product conversion rate was >98.7%, yield >81.5%, and ee value >99%. HPLC analysis showed that the crude enzyme solution converted some of the substrate into impurities other than the product, which not only reduced the yield but also increased the difficulty of subsequent product separation and purification.

[0046] Example 6. Enzymatic reaction to produce 6-S-tetrahydrofolate

[0047] The reaction time was changed to 2 hours. The remaining steps and conditions were the same as in Example 3.

[0048] The calculated product conversion rate is >97.5%, yield >92.7%, and ee value >99%.

[0049] Example 7. Enzymatic reaction to produce 6-S-tetrahydrofolate

[0050] Replace 7 ml of 20 mM PBS solution with 8.5 ml of 20 mM PBS solution, and replace 3 ml (16.7 mg) of the purified dihydrofolate reductase (DHFR-1) enzyme solution obtained in step 2.2 with 1.5 ml (8.35 mg) of the purified dihydrofolate reductase (DHFR-1) enzyme solution obtained in step 2.2. Change the reaction time to 2 hours. The remaining steps and conditions are the same as in Example 3.

[0051] The calculated product conversion rate is >97.3%, yield >92.5%, and ee value >99%.

[0052] Example 8. Enzymatic reaction to produce 6-S-tetrahydrofolate

[0053] Using the dihydrofolate obtained in Example 1 as a substrate, 70g of substrate, 126g of NADPH, and 550ml of 20mM PBS solution were added to a 1L glass reaction flask. Then, 100ml (556.7mg) of the purified dihydrofolate reductase DHFR-1 enzyme solution obtained in step 2.2 was added to the reaction flask to start the reaction. The reaction temperature was 37℃, the pH of the reaction solution was controlled at 7.5, and the mixture was stirred evenly for 3 hours.

[0054] After the above reaction is completed, the solution is thermally deactivated. After passing through a 0.22 μm filter membrane, 5 μl of the solution is taken and analyzed by high performance liquid chromatography to calculate its conversion rate >96.5%, yield >92.1%, and ee value >99%.

[0055] Example 9. Expression and purification of glucose dehydrogenase

[0056] 9.1 Escherichia coli containing glucose dehydrogenase sequence was picked and cultured in LB medium containing kanamycin at 37°C until the OD reached approximately 0.8. Then, IPTG was added to a final concentration of 0.1 mM, and the culture was induced at 28°C for 16 h. The bacterial culture was then centrifuged at 7000 g / min for 6 min to collect the cells. After discarding the supernatant, the cells were resuspended in 20 mM PBS solution at a ratio of 1 g: 5 ml. The resuspended cells were then disrupted using a high-pressure cell disruptor to obtain an enzyme-containing lysate. After centrifugation at 35000 g / min for 30 min, the supernatant was extracted to obtain a crude glucose dehydrogenase enzyme solution.

[0057] 9.2 The crude glucose dehydrogenase solution was then passed through a Ni column, followed by washing with 150 mM imidazole solution, then elution with 500 mM imidazole solution. All Ni column eluent containing the target enzyme was then passed through a Q column, followed by washing with 200 mM salt solution, then elution with 1 M salt solution (mainly KCl) to obtain a preliminarily purified enzyme solution. The preliminarily purified enzyme solution was dialyzed for 12 hours to finally obtain the purified glucose dehydrogenase solution.

[0058] Example 10: Combined enzymatic reaction to generate 6-S-tetrahydrofolate

[0059] Using the dihydrofolate obtained in Example 1 as a substrate, 1g of substrate, 0.5g of glucose, 0.1g of NADPH, and 7.5ml of 20mM PBS solution were added to a 50mL glass reaction flask. Then, 1.5ml of the purified dihydrofolate reductase DHFR-1 enzyme solution obtained in step 2.2 and 1ml of the crude glucose dehydrogenase enzyme solution obtained in step 9.1 were added to the reaction flask to start the reaction. The reaction temperature was 37℃, the pH of the reaction solution was controlled at 7.5, and the reaction was carried out for 2 hours after stirring.

[0060] After the above reaction is completed, the solution is thermally deactivated. After passing through a 0.22 μm filter membrane, 5 μl of the solution is taken and analyzed by high performance liquid chromatography to calculate its conversion rate >97.1%, yield >92.3%, and ee value >99%.

[0061] Example 11: Combined enzymatic reaction to generate 6-S-tetrahydrofolate

[0062] Replace 1 ml of the crude glucose dehydrogenase solution obtained in step 9.1 with the purified glucose dehydrogenase solution obtained in step 9.2. The remaining steps and conditions are the same as in Example 10.

[0063] The calculated product conversion rate is >97.2%, yield is >92.3%, and ee value is >99%.

[0064] Example 12 Immobilized enzymatic reaction to generate 6-S-tetrahydrofolate

[0065] 12.1 Immobilization of dihydrofolate reductase

[0066] The amino resin was washed three times with 20 mM PBS buffer and then filtered. A 2% glutaraldehyde solution was prepared with 20 mM PBS and mixed with the amino resin at a ratio of 1:4 (mass / volume ratio). The mixture was then stirred / shaken at 20°C for 1 hour and then filtered to obtain the amino resin. The amino resin was washed three times with 20 mM PBS buffer and then filtered. The purified enzyme solution containing approximately 200 mg of dihydrofolate reductase prepared in step 2.2 was then mixed with 4 g of amino resin (protein concentration was determined by standard protein content assay method). The mixture was then shaken at 80 rpm at 20°C for 18 hours. The amino resin was then collected by filtration (the filtrate can be used to determine the enzyme immobilization rate). The amino resin was washed three times with 20 mM PBS buffer and then filtered to obtain the immobilized dihydrofolate reductase DHFR-1. The immobilized enzyme was then loaded into a tank reactor.

[0067] 12.2 Immobilized enzymatic reaction to generate 6-S-tetrahydrofolate

[0068] Using the dihydrofolate obtained in Example 1 as a substrate, 1g of substrate and 1.8g of NADPH were dissolved in 10ml of 20mM PBS solution. The solution was then poured into the tank reactor containing immobilized dihydrofolate reductase DHFR-1 as described in 10.1 to start the reaction. The reaction temperature was maintained at 37°C, the pH of the reaction solution was controlled at 7.5, and the mixture was stirred until homogeneous for 2 hours.

[0069] After the above reaction is completed, the solution is filtered through a 0.22 μm filter membrane, and 5 μl of the solution is taken for high performance liquid chromatography (HPLC) to detect and calculate its conversion rate > 97.1%, yield > 92.3%, and ee value > 99%.

[0070] Example 13. Immobilized enzymatic reaction to generate 6-S-tetrahydrofolate

[0071] 13.1 Immobilization of dihydrofolate reductase

[0072] The epoxy resin was washed three times with 20 mM PBS buffer and then filtered. The purified enzyme solution containing approximately 200 mg of dihydrofolate reductase prepared in step 2.2 was then mixed with 8 g of epoxy resin (the protein concentration was determined by a standard protein content assay method). After mixing, the mixture was shaken at 200 rpm for 18 hours at 20°C and then allowed to stand for 20 hours. The epoxy resin was then collected by filtration (the filtrate can be used to determine the enzyme immobilization rate). The resin was washed three times with 20 mM PBS buffer and then filtered to obtain the immobilized dihydrofolate reductase DHFR-1. The immobilized enzyme was then loaded into a tank reactor.

[0073] 13.2 Immobilized enzymatic reaction to generate 6-S-tetrahydrofolate

[0074] Using the dihydrofolate obtained in Example 1 as a substrate, 1g of substrate and 1.8g of NADPH were dissolved in 10ml of 20mM PBS solution. The solution was then poured into the tank reactor containing immobilized dihydrofolate reductase DHFR-1 as described in 11.1 to start the reaction. The reaction temperature was maintained at 37°C, the pH of the reaction solution was controlled at 7.5, and the reaction was carried out for 2 hours after stirring.

[0075] After the above reaction is completed, the solution is filtered through a 0.22 μm filter membrane, and 5 μl of the solution is taken for high performance liquid chromatography (HPLC) to detect and calculate its conversion rate > 98.7%, yield > 94.3%, and ee value > 99%.

[0076] Example 14. Immobilized enzymatic reaction to generate 6-S-tetrahydrofolate

[0077] Using the dihydrofolate obtained in Example 1 as a substrate, 50g of substrate and 90g of NADPH were dissolved in 500ml of 20mM PBS solution. The solution was then poured into the tank reactor containing immobilized dihydrofolate reductase DHFR-1 as described in 13.1 to start the reaction. The reaction temperature was 37°C, the pH of the reaction solution was controlled at 7.5, and the reaction was carried out for 6 hours after stirring.

[0078] After the above reaction is completed, the solution is filtered through a 0.22 μm filter membrane, and 10 μl of the solution is taken for high performance liquid chromatography (HPLC) to determine its conversion rate > 92.3%, yield > 90.2%, and ee value > 99%.

[0079] Example 15. Immobilized enzymatic reaction to generate 6-S-tetrahydrofolate

[0080] 15.1 Immobilization of dihydrofolate reductase

[0081] The epoxy resin was washed three times with 20 mM PBS buffer and then filtered. The crude enzyme solution containing approximately 200 mg of dihydrofolate reductase prepared in step 2.2 was then mixed with 8 g of epoxy resin (the protein concentration was determined by a standard protein content assay method). After mixing, the mixture was shaken at 200 rpm for 18 hours at 20°C and then allowed to stand for 20 hours. The epoxy resin was then collected by filtration (the filtrate can be used to determine the enzyme immobilization rate). The resin was washed three times with 20 mM PBS buffer and then filtered to obtain the immobilized dihydrofolate reductase DHFR-1. The immobilized enzyme was then packed into a column reactor.

[0082] 15.2 Immobilized enzymatic reaction to generate 6-S-tetrahydrofolate

[0083] Using the dihydrofolate obtained in Example 1 as a substrate, 1g of substrate and 1.8g of NADPH were dissolved in 10ml of 20mM PBS solution, and the pH of the solution was adjusted to 7.5. The solution was then passed through a column reactor containing immobilized dihydrofolate reductase DHFR-1 in 13.1. The reaction temperature was controlled at 37°C, and the total flow time (i.e., reaction time) was controlled at 1h.

[0084] After the above reaction is completed, the solution is filtered through a 0.22 μm filter membrane, and 5 μl of the solution is taken for high performance liquid chromatography (HPLC) to calculate its conversion rate > 96.5%; yield > 92.2%; and ee value > 99%.

[0085] Example 16. Immobilized enzymatic reaction to generate 6-S-tetrahydrofolate

[0086] Using the dihydrofolate obtained in Example 1 as a substrate, 50g of substrate and 90g of NADPH were dissolved in 500ml of 20mM PBS solution, and the pH of the solution was adjusted to 7.5. The solution was then passed through a column reactor containing immobilized dihydrofolate reductase DHFR-1 prepared in Example 15.1. The reaction temperature was controlled at 37°C, and the total flow time (i.e., reaction time) was controlled at 6h.

[0087] During the above reaction process, reaction solutions were taken at different time points. After passing the reaction solution through a 0.22 μm filter membrane, 5 μl of the solution was taken and analyzed by high performance liquid chromatography. The conversion rate was found to be >92.5%; the final yield was >89.6% and the ee value was >99%.

[0088] Example 17. Combination immobilized enzyme catalysis of dihydrofolate reduction to 6-S-tetrahydrofolate

[0089] 17.1 Immobilization of combinatorial enzymes

[0090] The epoxy resin was washed three times with 20 mM PBS buffer and then filtered. The purified enzyme solution containing approximately 200 mg of dihydrofolate reductase prepared in step 2.2 was then mixed with 8 g of epoxy resin (the protein concentration was determined by a standard protein content assay method). After mixing, the mixture was shaken at 200 rpm for 18 hours at 20°C and then allowed to stand for 20 hours. The epoxy resin was then collected by filtration (the filtrate can be used to determine the enzyme immobilization rate). The resin was washed three times with 20 mM PBS buffer and then filtered to obtain the immobilized dihydrofolate reductase DHFR-1. The immobilized enzyme was then loaded into a tank reactor.

[0091] The epoxy resin was washed three times with 20 mM PBS buffer and then filtered. The crude enzyme solution containing approximately 100 mg of glucose dehydrogenase prepared in step 8.1 was then mixed with 4 g of epoxy resin (the protein concentration was determined by a standard protein content assay). After mixing, the mixture was shaken at 200 rpm for 18 hours at 20°C and then allowed to stand for 20 hours. The epoxy resin was then collected by filtration (the filtrate can be used to determine the enzyme immobilization rate). The resin was washed three times with 20 mM PBS buffer and then filtered to obtain the immobilized glucose dehydrogenase. The immobilized enzyme was then loaded into a tank reactor containing the previously immobilized dihydrofolate reductase DHFR-1.

[0092] 17.2 Combination immobilized enzyme catalyzes the reduction of dihydrofolate to 6-S-tetrahydrofolate

[0093] Using the dihydrofolate obtained in Example 1 as a substrate, 50g of substrate, 28g of glucose, and 1g of NADPH were dissolved in 500ml of 20mM PBS solution. The solution was then poured into the tank reactor containing immobilized dihydrofolate reductase DHFR-1 and immobilized glucose dehydrogenase as described in 15.1 to start the reaction. The reaction temperature was 37°C, the pH of the reaction solution was controlled at 7.5, and the reaction was carried out for 6 hours after stirring.

[0094] After the above reaction is completed, the solution is thermally deactivated. After passing through a 0.22 μm filter membrane, 5 μl of the solution is taken and analyzed by high performance liquid chromatography to calculate its conversion rate >95.9%, yield >91.7%, and ee value >99%.

[0095] Example 18. Enzymatic reduction of dihydrofolate to 6-S-tetrahydrofolate

[0096] The vector construction and cloning, enzyme expression, and purification procedures were the same as in Example 2, except that the type of dihydrofolate reductase was changed, with SEQ ID NO. 5 replaced by SEQ ID NO. 6, SEQ ID NO. 7, and SEQ ID NO. 8, respectively. The in vitro enzyme-catalyzed reaction steps were the same as in Example 3, and the final reaction results are as follows:

[0097] dihydrofolate reductase Conversion rate % Yield % ee value % DHFR-2 >93.1% >89.2% >99 DHFR-3 >97.8% >93.1% >99 DHFR-4 >95.6% >90.4% >99

[0098] Example 19. Immobilized enzymatic reaction to reduce dihydrofolate to 6-S-tetrahydrofolate

[0099] The vector construction and cloning, enzyme expression and purification procedures were the same as in Example 2. The enzyme immobilization and enzyme-catalyzed reaction procedures were the same as in Example 11. The difference was that the type of dihydrofolate reductase was changed, with SEQ ID NO. 5 replaced by SEQ ID NO. 6, SEQ ID NO. 7, and SEQ ID NO. 8, respectively. The final reaction results are as follows:

[0100] dihydrofolate reductase Conversion rate % Yield % ee value % DHFR-2 >97% >90.2% >99 DHFR-3 >98.2% >95.6% >99 DHFR-4 >96.8% >93.5% >99

Claims

1. A dihydrofolate reductase, characterized in that, The amino acid sequence of the dihydrofolate reductase is shown in SEQ ID NO.

3.

2. A gene encoding the dihydrofolate reductase of claim 1.

3. The gene for dihydrofolate reductase according to claim 2, characterized in that, The nucleotide sequence of the gene is shown in SEQ ID NO.

7.

4. The use of the dihydrofolate reductase of claim 1, or the gene of claim 2 or 3, in the in vitro biosynthesis of 6-S-tetrahydrofolate.

5. A method for the in vitro biosynthesis of 6-S- tetrahydrofolate, characterized in that, Includes the following steps: A recombinant vector containing the gene for dihydrofolate reductase as described in claim 2 or 3 was constructed, and the recombinant vector was transferred into Escherichia coli to obtain a recombinant Escherichia coli culture. The recombinant Escherichia coli culture was lysed to obtain a dihydrofolate reductase solution. Folic acid, sodium hydroxide aqueous solution and reducing agent were mixed to obtain dihydrofolate. Dihydrofolate, dihydrofolate reductase solution and coenzyme factor were mixed to carry out an enzymatic reaction. After the reaction was completed, 6-S-tetrahydrofolate was obtained.

6. The method of in vitro biosynthesis of 6-S- tetrahydrofolate according to claim 5, characterized in that, It also includes purification of dihydrofolate reductase solution and / or immobilized enzyme treatment.

7. The method of claim 5, wherein the 6-S-THF is synthesized in vitro. The reducing agent is zinc powder or sodium dithionite.

8. The method for in vitro biosynthesis of 6-S-tetrahydrofolate according to claim 5, characterized in that, The coenzyme factor is NADH or NADPH, the temperature of the enzymatic reaction is 20-45℃, the pH value of the enzymatic reaction is 5-9, and the reaction time is 1-24h.

9. The method for in vitro biosynthesis of 6-S-tetrahydrofolate according to claim 5, characterized in that, The mass ratio of the coenzyme factor to dihydrofolate is 0.1-3:1, and the mass ratio of the dihydrofolate reductase solution to dihydrofolate is 0.002-0.01:

1.

10. The method for in vitro biosynthesis of 6-S-tetrahydrofolate according to claim 5, characterized in that, The enzymatic reaction also includes glucose and glucose dehydrogenase. The mass ratio of glucose, dihydrofolate, and coenzyme factor is 0.4-1:1:0.01-1, and the mass ratio of glucose to glucose dehydrogenase is 0.001-0.01:1.

Citation Information

Patent Citations

  • Preparation method and application of recombinant streptococcus pneumoniae dihydrofolate reductase

    CN108866019A

  • Natural (6S)-5-methyltetrahydrofolate and preparation method thereof

    CN115161359A